Summary

The Global Bone & Joint Health Supplements Market is valued approximately at USD 4.17 billion in 2024 and is anticipated to expand with an impressive CAGR of 7.20% over the forecast period 2025–2035. Amid the paradigm shift towards preventive healthcare and holistic wellness, the demand for bone and joint health supplements is witnessing an unprecedented surge across the globe. The aging population, rising awareness of musculoskeletal health, and the surge in lifestyle-induced orthopedic conditions are playing instrumental roles in accelerating market growth. Consumers are increasingly prioritizing proactive measures to mitigate age-related joint deterioration and bone density loss, driving a consistent uptrend in supplement intake. Moreover, the preference for non-pharmaceutical alternatives has underscored the significance of nutraceuticals fortified with calcium, vitamin D, magnesium, and other joint-supporting compounds.
This upward trajectory is further catalyzed by the proliferation of fitness culture, increasing sports participation, and the global rise in osteoarthritis and osteoporosis prevalence. With urban professionals and geriatric consumers alike seeking functional foods and dietary solutions to maintain joint mobility and skeletal integrity, formulators are innovating with high-bioavailability ingredients such as hydrolyzed collagen, glucosamine, and omega-3 fatty acids. As a result, brands are focusing on optimizing product delivery formats—ranging from capsules and gummies to powders and functional beverages—to enhance compliance and consumer engagement. Additionally, growing clinical substantiation and scientific backing for these formulations are legitimizing their efficacy and widening their mainstream appeal.
From a geographical lens, North America dominates the market landscape, primarily fueled by its robust consumer base, aging baby boomers, and strong retail penetration for dietary supplements. The U.S. continues to lead in supplement consumption, bolstered by healthcare expenditure and a culture inclined towards wellness. Meanwhile, Europe is not far behind, supported by preventive care policies and rising osteoporosis-related concerns, especially among women. However, Asia Pacific is poised to exhibit the fastest growth during the forecast period, driven by rapid urbanization, growing middle-class affluence, and evolving dietary habits in countries like China, India, and Japan. The region is also witnessing increasing governmental efforts and private investments aimed at promoting nutritional interventions in public health systems.
Major market player included in this report are:
• BASF SE
• Kerry Group plc
• Chr. Hansen Holding A/S
• Novozymes A/S
• DSM-Firmenich
• Glanbia plc
• Amway Corp.
• NOW Health Group, Inc.
• Reckitt Benckiser Group PLC
• Bayer AG
• Nestlé Health Science
• Herbalife Nutrition Ltd.
• Abbott Laboratories
• Nature’s Bounty Co.
• Pfizer Inc.
Global Bone & Joint Health Supplements Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period – 2025–2035
• Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope – Free report customization (equivalent up to 8 analysts’ working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.
The detailed segments and sub-segments of the market are explained below:
By Product:
• Vitamins
• Minerals
• Collagen
• Omega-3
• Glucosamine
By Formulation:
• Capsules
• Tablets
• Powders
• Gummies
• Softgels
• Others
By Consumer Group:
• Adults
• Geriatric Population
• Pregnant Women
• Children
By Sales Channel:
• Supermarkets & Hypermarkets
• Pharmacy & Drug Stores
• Online Sales Channels
• Specialty Stores
• Others
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1. Global Bone & Joint Health Supplements Market Report Scope & Methodology
1.1. Research Objective
1.2. Research Methodology
 1.2.1. Forecast Model
 1.2.2. Desk Research
 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
 1.4.1. Market Definition
 1.4.2. Market Segmentation
1.5. Research Assumption
 1.5.1. Inclusion & Exclusion
 1.5.2. Limitations
 1.5.3. Years Considered for the Study
Chapter 2. Executive Summary
2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings
Chapter 3. Global Bone & Joint Health Supplements Market Forces Analysis (2024–2035)
3.1. Market Forces Shaping The Global Bone & Joint Health Supplements Market
3.2. Drivers
 3.2.1. Rising geriatric population globally
 3.2.2. Growing demand for preventive healthcare solutions
 3.2.3. Increased participation in fitness and sports activities
3.3. Restraints
 3.3.1. Lack of consumer awareness in underdeveloped regions
 3.3.2. Stringent regulations on health supplement claims
3.4. Opportunities
 3.4.1. Rising e-commerce adoption for supplement sales
 3.4.2. Innovation in high-bioavailability supplement formulations
Chapter 4. Global Bone & Joint Health Supplements Industry Analysis
4.1. Porter’s 5 Forces Model
 4.1.1. Bargaining Power of Buyer
 4.1.2. Bargaining Power of Supplier
 4.1.3. Threat of New Entrants
 4.1.4. Threat of Substitutes
 4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Forecast Model (2024–2035)
4.3. PESTEL Analysis
 4.3.1. Political
 4.3.2. Economical
 4.3.3. Social
 4.3.4. Technological
 4.3.5. Environmental
 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024–2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion
Chapter 5. Global Bone & Joint Health Supplements Market Size & Forecasts by Product 2025–2035
5.1. Market Overview
5.2. Global Bone & Joint Health Supplements Market Performance – Potential Analysis (2025)
5.3. Vitamins
 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
 5.3.2. Market size analysis, by region, 2025–2035
5.4. Minerals
 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
 5.4.2. Market size analysis, by region, 2025–2035
5.5. Collagen
5.6. Omega-3
5.7. Glucosamine
Chapter 6. Global Bone & Joint Health Supplements Market Size & Forecasts by Formulation 2025–2035
6.1. Market Overview
6.2. Global Bone & Joint Health Supplements Market Performance – Potential Analysis (2025)
6.3. Capsules
6.4. Tablets
6.5. Powders
6.6. Gummies
6.7. Softgels
6.8. Others
Chapter 7. Global Bone & Joint Health Supplements Market Size & Forecasts by Consumer Group 2025–2035
7.1. Market Overview
7.2. Adults
7.3. Geriatric Population
7.4. Pregnant Women
7.5. Children
Chapter 8. Global Bone & Joint Health Supplements Market Size & Forecasts by Sales Channel 2025–2035
8.1. Market Overview
8.2. Supermarkets & Hypermarkets
8.3. Pharmacy & Drug Stores
8.4. Online Sales Channels
8.5. Specialty Stores
8.6. Others
Chapter 9. Global Bone & Joint Health Supplements Market Size & Forecasts by Region 2025–2035
9.1. Global Bone & Joint Health Supplements Market, Regional Market Snapshot
9.2. Top Leading & Emerging Countries
9.3. North America Bone & Joint Health Supplements Market
 9.3.1. U.S.
 9.3.1.1. Product breakdown size & forecasts, 2025–2035
 9.3.1.2. Formulation breakdown size & forecasts, 2025–2035
 9.3.2. Canada
 9.3.2.1. Product breakdown size & forecasts, 2025–2035
 9.3.2.2. Formulation breakdown size & forecasts, 2025–2035
9.4. Europe Bone & Joint Health Supplements Market
 9.4.1. UK
 9.4.2. Germany
 9.4.3. France
 9.4.4. Spain
 9.4.5. Italy
 9.4.6. Rest of Europe
9.5. Asia Pacific Bone & Joint Health Supplements Market
 9.5.1. China
 9.5.2. India
 9.5.3. Japan
 9.5.4. Australia
 9.5.5. South Korea
 9.5.6. Rest of Asia Pacific
9.6. Latin America Bone & Joint Health Supplements Market
 9.6.1. Brazil
 9.6.2. Mexico
9.7. Middle East & Africa Bone & Joint Health Supplements Market
 9.7.1. UAE
 9.7.2. Saudi Arabia
 9.7.3. South Africa
 9.7.4. Rest of Middle East & Africa
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. BASF SE
 10.2.1. Company Overview
 10.2.2. Key Executives
 10.2.3. Company Snapshot
 10.2.4. Financial Performance (Subject to Data Availability)
 10.2.5. Product/Services Port
 10.2.6. Recent Development
 10.2.7. Market Strategies
 10.2.8. SWOT Analysis
10.3. Kerry Group plc
10.4. Chr. Hansen Holding A/S
10.5. Novozymes A/S
10.6. DSM-Firmenich
10.7. Glanbia plc
10.8. Amway Corp.
10.9. NOW Health Group, Inc.
10.10. Reckitt Benckiser Group PLC
10.11. Bayer AG
10.12. Nestlé Health Science
10.13. Herbalife Nutrition Ltd.
10.14. Abbott Laboratories
10.15. Nature’s Bounty Co.
10.16. Pfizer Inc.